false 0001220754 0001220754 2022-10-27 2022-10-27
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): October 27, 2022
 
ModivCare Inc.
(Exact name of registrant as specified in its charter)
 
         
Delaware
 
001-34221
 
86-0845127
(State or other jurisdiction
of incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer
Identification No.)
   
6900 Layton Avenue, 12th Floor
Denver, Colorado
 
80237
(Address of principal executive offices)
 
(Zip Code)
 
 
Registrants telephone number, including area code: (303) 728-7030

 
N/A

(Former name or former address, if changed since last report)
 
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 Par Value
MODV
The NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 

 
Item 5.02
Departure of Directors or Certain Officers: Election of Directors: Appointment of Certain Officers: Compensatory Arrangements of Certain Officers.
 
(b)          On October 27, 2022, Walt Meffert’s service as Chief Information Officer for the registrant was terminated, effective December 31, 2022, and on February 3, 2023, Grover N. Wray’s service as Chief Human Resources Officer for the registrant was terminated, effective February 17, 2023.
 
Item 9.01
Financial Statements and Exhibits.
 
(d)          Exhibits.
 
Exhibit
Number
 
Description
104
 
Cover Page Interactive Data File (embedded within Inline XBRL document).
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
MODIVCARE INC.
Date: February 9, 2023 
By:
/s/ Jonathan B. Bush
Name:
Jonathan B. Bush
Title:
SVP, General Counsel & Secretary
 
 
       
 
         
 
         
 
ModivCare (NASDAQ:MODV)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 ModivCare 차트를 더 보려면 여기를 클릭.
ModivCare (NASDAQ:MODV)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 ModivCare 차트를 더 보려면 여기를 클릭.